TABLE 3

Results for prospective samplesa

TargetNo. of TP/no. of TP + FNPPA (%) (95% CI)No. of TN/no. of TN + FPNPA (%) (95% CI)
Adenovirus54/6188.5 (78.2–94.3)2,373/2,40198.8 (98.3–99.2)
Coronavirus96/11782.1 (74.1–88.0)2,331/2,34599.4 (99.0–99.6)
Human metapneumovirus107/11394.7 (88.9–97.5)2,343/2,34999.7 (99.4–99.9)
Human rhinovirus/enterovirus493/51995.0 (92.8–96.6)1,860/1,94395.7 (94.7–96.5)
Influenza A virus106/11195.5 (89.9–98.1)2,347/2,35199.8 (99.6–99.9)
Influenza A H1 virus0/02,462/2,462100 (99.8–100)
Influenza A 2009 H1N1 virus70/7198.6 (92.4–99.8)2,385/2,39199.7 (99.5–99.9)
Influenza A H3 virus34/3791.9 (78.7–97.2)2,425/2,425100 (99.8–100)
Influenza B virus59/6689.4 (79.7–94.8)2,391/2,39699.8 (99.5–99.9)
Parainfluenza virus 124/2596.0 (80.5–99.3)2,436/2,437100 (99.8–100)
Parainfluenza virus 221/2295.5 (78.2–99.2)2,438/2,44099.9 (99.7–100)
Parainfluenza virus 399/10990.8 (83.9–94.9)2,348/2,35399.8 (99.5–99.9)
Parainfluenza virus 48/8100 (67.6–100)2,447/2,45499.7 (99.4–99.9)
Respiratory syncytial virus subtype A35/4087.5 (73.9–94.5)2,418/2,419100 (99.8–100)
Respiratory syncytial virus subtype B90/9693.8 (87.0–97.1)2,361/2,36399.9 (99.7–100)
Chlamydia pneumoniae2/540.0 (11.8–76.9)2,456/2,457100 (99.8–100)
Mycoplasma pneumoniae7/887.5 (52.9–97.8)2,452/2,45499.9 (99.7–100)
  • a FP, false-positive results; FN, false-negative results; TP, true-positive results; TN, true-negative results; PPA, positive percent agreement; NPA, negative percent agreement (defined in comparison to the comparator method); CI, confidence interval.